Original fundamental research starts and ENDS here.
Sectors Tags Blog
BSX
5 filings
Timeline Columns Start Research 8-K Categories
Showing: Other Clear filter
2025
Q4 1 filings
Nov
2026 Compensation Plans Approved
Annual bonus plan with 0-225% payout range, performance shares tied to TSR and organic sales growth
8-K
Q2 1 filings
May
Discontinued ACURATE Valve Systems
Worldwide discontinuation of ACURATE neo2 and Prime Aortic Valve Systems
8-K
2024
Q4 2 filings
Nov
2025 Compensation Plans Approved
Annual bonus plan with 0-225% payout range, performance shares with 0-200% range
8-K
Nov
Resumed AVANT GUARD Clinical Trial
Trial studying drug-naïve patients with persistent atrial fibrillation resumed after data monitoring committee assessment
8-K
Q2 1 filings
May
New Director Appointed & Credit Line Extended
Dr. Cheryl Pegus joins board, $2.75B credit facility extended to 2029
8-K
SECENDS is not affiliated with the SEC. Data from public EDGAR filings. Not financial advice.